SafeBeat vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-09
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionSafeBeatIsomorphic Labs
Target UsersElectrophysiologists, cardiologistsLarge pharma companies
Core TechAI ECG interpretation, remote therapeutic monitoringAlphaFold, AI for protein-ligand interactions, generative molecule design
Regulatory StatusInvestigational use onlyResearch/partnership stage
Key PartnershipsKardiaMobile, Zio, Reveal LINQ, Confirm RxNovartis, Johnson & Johnson

Isomorphic Labs leads in AI-driven drug discovery with DeepMind backing and major pharma partnerships, but only for large-scale collaboration. SafeBeat targets a narrower cardiac niche, offering practical remote monitoring but remains in investigational stage. Choose Isomorphic for drug R&D; choose SafeBeat for cardiac therapeutic management if approved.

SafeBeat
SafeBeat

SafeBeat is an investigational AI ECG analysis platform that guides cardiac drug initiation and adjustment from a phone.

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs applies generative AI drug discovery to design novel molecules and predict how candidates will perform.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
—
—
Popularity
3 views
7.5k views
Skill Level
Advanced
Advanced
API Available
Platforms
Mobile
—
Categories
🏥 Healthcare
🧬 Drug Discovery & Life Sciences
Features
AI-based ECG interpretation for cardiac assessment
Guidance for cardiac medication initiation and adjustment
Remote therapeutic monitoring workflow guided from a smartphone
Explainable AI outputs designed for clinician review
Customizable, patient-specific treatment steps
Ingests mobile ECG, mobile cardiac telemetry, and implantable cardiac monitor data
Cloud dashboard for multi-patient review from a phone
Alert-triage design intended to reduce clinician alert fatigue
Patient symptom logging
API for EHR integration
Software licensed to third parties to power their own products
SOC 2 Type 2 compliant operations
HIPAA-compliant data handling
All software streamlined for use from a mobile phone
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Builds on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Series B investment round announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Interdisciplinary team of drug discovery experts and ML specialists
Founded by Demis Hassabis, who serves as CEO
Integrations
KardiaMobile
Zio
Reveal LINQ
Confirm Rx

Who should pick which

  • Large pharma R&D executive
    Pick: Isomorphic Labs

    Access to AlphaFold-based drug design engine and established partnerships with Novartis, J&J enable accelerated lead optimization for large-scale programs.

  • Electrophysiologist managing AFib remotely
    Pick: SafeBeat

    AI-powered ECG analysis with actionable treatment recommendations and integration with common devices reduces alert fatigue and enables remote medication titration.

  • Startup seeking AI drug discovery API
    Pick: Isomorphic Labs

    Not suitable — Isomorphic Labs only partners with large pharma and does not offer an API or standalone software.

  • Hospital system wanting ready-to-use cardiac monitoring
    Pick: SafeBeat

    Limited — SafeBeat is still in investigational use; no FDA-cleared commercial product available today.

  • Researcher in computational biology
    Pick: Isomorphic Labs

    Access to digital biology simulation at scale, but only via partnership; not for individual research.

Frequently Asked Questions

SafeBeat vs Isomorphic Labs: which should you choose?

Isomorphic Labs leads in AI-driven drug discovery with DeepMind backing and major pharma partnerships, but only for large-scale collaboration. SafeBeat targets a narrower cardiac niche, offering practical remote monitoring but remains in investigational stage. Choose Isomorphic for drug R&D; choose SafeBeat for cardiac therapeutic management if approved.

Do either tools offer a public API?

No. Isomorphic Labs operates through exclusive pharma partnerships; SafeBeat is investigational and not yet commercially available.

Is SafeBeat FDA-cleared?

No. SafeBeat is currently limited to investigational use and not yet cleared by FDA.

Which tool is better for drug discovery?

Isomorphic Labs, leveraging AlphaFold and deep pharma collaborations, is purpose-built for AI-driven drug design.

Can SafeBeat be used for emergency cardiac events?

No. It is designed for remote therapeutic monitoring, not acute event detection.

What devices does SafeBeat integrate with?

KardiaMobile, Zio, Reveal LINQ, and Confirm Rx.

Is Isomorphic Labs a software company?

No. It's a drug discovery company that uses AI internally; it does not sell software.

What is the latest funding for Isomorphic Labs?

Series B in February 2026 (undisclosed amount), following a $600M external round in 2025.

Which tool has explainable AI?

SafeBeat offers explainable AI outputs for clinical decision support; Isomorphic Labs does not emphasize explainability in its offerings.

More SafeBeat or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026